Title:
CANCER TREATMENT AGENT
Document Type and Number:
Japanese Patent JP2021080301
Kind Code:
A
Abstract:
To provide an infection treatment agent characterized by administering an effective amount of a PD-L1 antibody that inhibits PD-1 immunosuppressive signals to a patient.SOLUTION: An effective amount of a PD-L1 antibody that inhibits PD-1 immunosuppressive signals is effective in infection treatment.SELECTED DRAWING: None
Inventors:
HONJO TASUKU
MINATO NAGAHIRO
IWAI YOSHIKO
SHIBAYAMA SHIRO
MINATO NAGAHIRO
IWAI YOSHIKO
SHIBAYAMA SHIRO
Application Number:
JP2021036417A
Publication Date:
May 27, 2021
Filing Date:
March 08, 2021
Export Citation:
Assignee:
ONO PHARMACEUTICAL CO
HONJO TASUKU
HONJO TASUKU
International Classes:
A61K39/395; A61K31/7088; A61K35/14; A61P31/00; A61P31/20; A61P35/00; A61P35/04; A61P37/04; C07K16/42; C12N15/02; C12P21/08; C12Q1/02; G01N33/50; G01N33/574
Domestic Patent References:
| JPH08501085A | 1996-02-06 | |||
| JPH10505339A | 1998-05-26 |
Foreign References:
| WO2001014557A1 | 2001-03-01 | |||
| WO2000002584A2 | 2000-01-20 | |||
| WO2000069463A1 | 2000-11-23 | |||
| WO2002000730A2 | 2002-01-03 | |||
| WO2002000692A2 | 2002-01-03 |
Other References:
NATURE IMMUNOLOGY, vol. 2, no. 3, JPN6023010973, 2001, pages 261 - 268, ISSN: 0005022188
NATURE MEDICINE, vol. 8, JPN6015008802, June 2002 (2002-06-01), pages 793 - 800, ISSN: 0004915770
BLOOD, vol. 97, no. 6, JPN6009036757, 2001, pages 1809 - 1816, ISSN: 0004915771
FASEB JOURNAL, vol. 16, no. 4, JPN7015002939, April 2002 (2002-04-01), pages 710 - 517, ISSN: 0004915772
NATURE MEDICINE, vol. 8, JPN6015008802, June 2002 (2002-06-01), pages 793 - 800, ISSN: 0004915770
BLOOD, vol. 97, no. 6, JPN6009036757, 2001, pages 1809 - 1816, ISSN: 0004915771
FASEB JOURNAL, vol. 16, no. 4, JPN7015002939, April 2002 (2002-04-01), pages 710 - 517, ISSN: 0004915772
Attorney, Agent or Firm:
Atsushi Aoki
Yoichi Watanabe
Masaru Nakajima
Ryotaro Takei
Yoichi Watanabe
Masaru Nakajima
Ryotaro Takei